In Silico and In Vitro Studies on an Asymmetrical Porphyrin Derivative with Therapeutic Potential in Skin Disorders.
HaCaT keratinocytes
Hs27 skin fibroblasts
asymmetrical porphyrin
carbonic anhydrase IX
molecular dynamics
photodynamic therapy
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
27 May 2024
27 May 2024
Historique:
received:
12
04
2024
revised:
23
05
2024
accepted:
24
05
2024
medline:
27
6
2024
pubmed:
27
6
2024
entrez:
27
6
2024
Statut:
epublish
Résumé
For developing novel photosensitizers with therapeutic potential in non-malignant and malignant cutaneous disorders, the unsymmetrical porphyrin, 5-(2-hydroxy-3-methoxyphenyl)-10, 15, 20-
Identifiants
pubmed: 38931355
pii: ph17060688
doi: 10.3390/ph17060688
pii:
doi:
Types de publication
Journal Article
Langues
eng